Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First- or Second- Class Compression Hosiery After Endovenous Laser With Sclerotherapy and Ambulatory Phlebectomy: Randomized Controlled Trial (FISCHER)

NCT06913764 is registered in ClinicalTrials.gov with Moscow City Hospital named after A.K. Eramishantsev as lead sponsor.

NCT NCT06913764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06913764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First- or Second- Class Compression Hosiery After Endovenous Laser With Sclerotherapy and Ambulatory Phlebectomy: Randomized Controlled Trial (FISCHER)
Lead sponsor
Moscow City Hospital named after A.K. Eramishantsev
Phase
Not applicable
Overall status
Completed
Start date
April 7, 2025
Completion date
July 2, 2025
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic venous disorder, chronic venous insufficiency (cvi), great saphenous vein (gsv) with venous reflux disease, varicose veins, venous reflux